Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEAT-meso: Atezolizumab + Bevacizumab + Chemotherapy in Advanced Malignant Pleural Mesothelioma
NCT03762018Phase 3Completed
- Sponsor
- ETOP IBCSG Partners Foundation
- Start
- Apr 2019
- Primary completion
- Sep 2023
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 3 trial of atezolizumab in malignant pleural mesothelioma (MPM), sponsored by ETOP IBCSG Partners Foundation. Started Apr 2019; status: completed.
02
Drugs
atezolizumab
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT03762018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03762018.